Actiq (Fentanyl) Use During Pregnancy: Risks, Safety & Treatment Options
Table of Contents
Key Takeaways
- Actiq is a fentanyl lozenge, and it isn't considered safe in pregnancy. Fentanyl crosses the placenta and can harm a fetus.
- Don't stop on your own. Abruptly stopping opioids in pregnancy can be dangerous, so any change belongs with a doctor.
- Prenatal opioid exposure can lead to NAS. Withdrawal signs in newborns usually start within 72 hours of birth.
- Treatment works. Methadone and buprenorphine are safe and effective in pregnancy for both parent and baby.
- We can help you find care. Reach Recovere helps you find pregnancy-informed treatment and figure out how to pay for it.
Actiq while pregnant isn’t safe, and if you’re reading this with a positive test in your hand, that’s a hard sentence to take in. Actiq is a transmucosal fentanyl lozenge, and the fentanyl in it passes across the placenta to the fetus. The same medicine that controls severe pain in an adult can suppress a newborn’s breathing and bring on withdrawal after birth.
If you took it before you knew you were pregnant, that’s common, and stopping cold on your own carries its own risk. Opioid use disorder in pregnancy responds well to treatment.
You might be here because you were prescribed Actiq for cancer pain, or because you’re living with fentanyl use disorder. Either way, fentanyl is a Schedule II opioid 50 to 100 times more potent than morphine, and the path forward is the same: find care that fits a pregnancy, then work out how to pay for it. That’s the Reach Recovere Find-and-Fund approach.
Is Actiq Safe to Take While Pregnant?
No. Actiq isn’t considered safe in pregnancy, and stopping it abruptly isn’t safe either.
The drug was approved for one narrow use: breakthrough pain in cancer patients 16 and older who already take around-the-clock opioids and are opioid tolerant. Its labeling carries the old Pregnancy Category C (a category that flags possible fetal risk, not a guarantee of safety, despite how patients often read it) and limits use to cases where the benefit outweighs the risk to the fetus. Most pregnancies don’t meet that bar.
A prescription doesn’t change the chemistry. A legitimate Actiq script for cancer pain delivers fentanyl to the fetus, and illicit fentanyl adds the danger of an unknown, often lethal dose. Either source crosses the placenta.
Talk to your provider before you stop or change anything, because abruptly stopping opioids in pregnancy can put stress on the fetus.
Why fentanyl is especially dangerous in pregnancy
Potency drives the risk. Fentanyl is 50 to 100 times stronger than morphine, and roughly 2 mg can be fatal. It’s a full opioid agonist, so it binds the mu-opioid receptors that control breathing and depresses respiration directly. The labeling opens with a boxed warning for fatal respiratory depression, the slowed, shallow breathing behind most opioid deaths. Combining it with certain CYP3A4-inhibiting drugs, which slow how fast the body clears fentanyl, raises blood levels and that same risk. Because fentanyl crosses the placenta freely, all of this reaches a fetus whose liver clears opioids slowly and whose respiratory drive is still forming.
Two milligrams is about the weight of a few grains of salt.
Why you should never stop Actiq suddenly
Quitting cold turkey is the wrong move, even though the urge to stop everything the moment you see a positive test is completely understandable. Sudden withdrawal can stress the fetus, so the safer route is a supervised change rather than an abrupt halt.
Tell a provider the day you find out you’re pregnant. They can move you onto maintenance treatment or a closely watched taper that keeps your opioid levels steady instead of swinging.
How Actiq Affects Pregnancy and the Developing Baby
Actiq can affect a pregnancy before birth and after it. Before birth, it adds a small but real increase to certain risks, and that increase sits on top of a baseline that exists for everyone. About 1 in 33 babies, close to 3%, is born with a birth defect with no drug exposure at all. Opioid use raises the odds beyond that baseline.
Dose and length of exposure matter here more than almost anything. A single supervised dose isn’t the same as months of high-dose use, and most studies can’t fully separate fentanyl’s effect from everything else happening in a pregnancy, so the guidance stays cautious.
Birth defects and fetal fentanyl syndrome
Opioid use in pregnancy has been linked to specific birth defects. Whether fentanyl produces a recognizable pattern of its own is a newer and less settled question.
In 2023, a case series of 10 infants exposed mostly to nonprescription fentanyl described a possible “fetal fentanyl syndrome”: microcephaly, short stature, cleft palate, and unusual facial features, a combination that resembled Smith-Lemli-Opitz syndrome, a disorder of cholesterol metabolism. These are early findings from a small group of children, not a confirmed diagnosis. If you’ve already been exposed, the difference between a handful of reported cases and an established cause is a real one.
Preterm birth, low birth weight & placental abruption
Beyond birth defects, opioids are linked to poor fetal growth, preterm birth, low birth weight, and stillbirth. Babies born before 37 weeks face higher odds of breathing and feeding problems, and low birth weight tends to accompany both early delivery and slow growth.
These are the complications prenatal monitoring is designed to catch early, which is one more reason to stay in regular contact with a provider once treatment starts.
Miscarriage and stillbirth risk
The evidence on miscarriage is genuinely limited, and it’s more honest to say so than to imply a clean number exists. Stillbirth appears among the outcomes tied to opioid use disorder in pregnancy, but most studies can’t separate fentanyl from polysubstance use and patchy prenatal care.
Misuse and overdose-level exposure raise the risk of pregnancy loss. A single monitored therapeutic dose is a different situation, and treatment lowers the danger by replacing erratic exposure with steady medical oversight.
Neonatal Abstinence Syndrome (NAS): Babies Born Dependent on Actiq
A baby exposed to opioids before birth can be born physically dependent and go through withdrawal. That’s neonatal abstinence syndrome, or NAS, and the opioid-specific form is neonatal opioid withdrawal syndrome (NOWS), the withdrawal that occurs in a newborn’s first 28 days. Hearing that your baby could withdraw is frightening, so the part to hold onto is that NAS is treatable and well understood.
A dependent newborn didn’t do anything. Dependence is a physical state the baby developed through exposure, and the care team’s whole focus is easing the infant through it.
Signs and symptoms of NAS
NAS signs usually appear within 72 hours of birth. The most common ones:
- Tremors (trembling) or seizures
- Sleep problems, irritability, or high-pitched crying
- Hyperactive reflexes
- Yawning, stuffy nose, or sneezing
- Poor feeding and sucking
- Loose stools, vomiting, or dehydration
- Increased sweating
How severe it gets depends on which substance, how much, when the last exposure was, whether the baby is full-term, and any other exposures. Exposed newborns are watched closely in the hospital rather than discharged on a normal timeline.
How NAS is diagnosed and treated
Treatment starts with supportive care: a dim, quiet room, swaddling, gentle rocking, frequent high-calorie feeds, and keeping the baby in the same room as the parent. Many infants improve with that alone and never need medication.
For more severe withdrawal, babies may be given liquid oral morphine or methadone to control seizures, feeding problems, diarrhea, and agitation, with the dose lowered gradually as symptoms ease. Treated infants often stay in the hospital longer, and families leave with a Plan of Safe Care that connects them to follow-up support after discharge.
Long-term outcomes for the child
Long-term outcomes are the least certain part of this picture. Most NAS care is short-term, and babies move through the acute withdrawal with proper treatment. The long-term effects of prenatal opioid exposure are largely unknown and still being studied.
Early, stable treatment and consistent follow-up are what the current evidence supports.
Pregnant and worried about Actiq or fentanyl? You don't have to sort it out alone.
Find Pregnancy-Informed TreatmentTreatment Options for Opioid Use During Pregnancy
The standard of care is medication, not stopping cold. For opioid use disorder in pregnancy, methadone and buprenorphine are safe and effective for pregnant patients and lead to better outcomes for both parent and baby. Steady, monitored treatment replaces the cycle of overdose risk and withdrawal.
Starting treatment is more accessible than many people expect, and the benefits of these medications outweigh the risks in pregnancy. A prenatal provider can connect that care to the rest of your maternity visits.
Medication-assisted treatment: methadone & buprenorphine
Methadone and buprenorphine are the two first-line treatments for opioid use disorder in pregnant and breastfeeding patients. Both stop withdrawal and reduce cravings. Buprenorphine (and despite what some patients are told, it doesn’t simply swap one addiction for another) is a partial opioid agonist, so it carries a lower overdose risk than a full agonist like methadone, while methadone has the longer track record in pregnancy.
| Methadone | Buprenorphine |
|---|---|
|
|
Which one fits depends on your history and what your care team advises. Both are far safer than continued fentanyl, and only very small amounts pass into breast milk.
Medically supervised withdrawal (and why it is not first-line)
Supervised detox during pregnancy usually isn’t first-line, and the reason is the high rate of return to use afterward. Going back to fentanyl once tolerance has dropped is a high-overdose situation that also threatens the pregnancy, so maintenance treatment is generally preferred over withdrawal.
There are specific settings where a provider and patient still consider a supervised taper. That’s a shared clinical decision made under close monitoring.
Pain-management alternatives to Actiq
If Actiq was prescribed for real pain, you still have options, and they run through your provider. Some pain can be managed with non-opioid medications or lower-risk approaches a clinician weighs against your needs, and any change should be coordinated with your doctor rather than made on your own. Severe pain sometimes still needs careful treatment, so the goal is the safest plan for both you and the baby.
Fentanyl, Actiq, and Breastfeeding
The answer depends on what you’re taking. While you’re actively using Actiq, the label advises against breastfeeding because fentanyl passes into milk and can cause sedation and slowed breathing in the infant.
Treatment changes that picture. For a parent stabilized on methadone or buprenorphine, breastfeeding is generally encouraged, with exceptions for illicit drug use, HIV, and use of more than one substance, and only trace amounts of those medications reach milk. Don’t wean abruptly, and watch the baby for unusual drowsiness or slowed breathing.
Fertility and Preconception Planning While Taking Actiq
If you’re planning a pregnancy while taking Actiq, start with a conversation about your opioid use before you try to conceive, so any medication change happens under supervision rather than after a positive test. The data on fentanyl and fertility are limited, which means the safest step for both partners is the same: ask a clinician where things stand and what a safer route to pregnancy looks like.
Finding Help for Actiq Addiction During Pregnancy
Reaching out protects two people at once. Treatment lowers overdose risk and improves pregnancy outcomes, and the earlier it begins, the more stable the pregnancy tends to be. Care for a pregnant patient is meant to be coordinated and non-judgmental, pairing addiction treatment with prenatal care.
In practice that means an assessment, a medication plan if it fits, coordination with your prenatal team, and continued support after delivery, since the weeks after birth carry their own return-to-use risk. We can help you find a program built for this and figure out how to cover it.
Find treatment that understands pregnancy, and get help covering the cost.
Find Treatment Near YouFrequently Asked Questions
What are the effects of prenatal fentanyl exposure?
Prenatal fentanyl exposure raises the risk of poor fetal growth, preterm birth, stillbirth, certain birth defects, and neonatal opioid withdrawal after birth. Most exposed babies who develop withdrawal recover from the acute phase with supportive hospital care.
How long does fentanyl stay in a fetus's system?
There's no precise published figure. Fentanyl crosses the placenta freely, and newborns clear opioids more slowly than adults, which is why exposed babies are monitored after birth. A clinician can give the most accurate guidance for your situation.
What happens if a pregnant woman takes opioids?
Opioid use in pregnancy raises the risk of poor fetal growth, preterm birth, stillbirth, birth defects, and neonatal withdrawal. Stopping abruptly is also risky, so treatment with methadone or buprenorphine, rather than sudden withdrawal, is the recommended approach.
What pregnancy category is fentanyl?
Fentanyl carried the historical Pregnancy Category C. The letter categories A through X were retired under the 2015 Pregnancy and Lactation Labeling Rule and replaced with a narrative risk summary. Current fentanyl labeling still warns of fetal risk and neonatal withdrawal.
References and Medical Sources
Reviewed by: [MEDICAL REVIEWER SLOT: credentialed reviewer to be assigned]. Written by: [AUTHOR SLOT]. Published June 5, 2026. Last updated June 19, 2026.
- U.S. Food and Drug Administration. Actiq (fentanyl citrate) oral transmucosal lozenge prescribing information.
- U.S. Food and Drug Administration. Questions and Answers: TIRF REMS, including Actiq discontinuation (Sept. 30, 2024).
- National Institute on Drug Abuse. Fentanyl, NIH.
- Centers for Disease Control and Prevention. Substance Use During Pregnancy.
- Centers for Disease Control and Prevention. Treat and Manage Infants Affected by Prenatal Opioid Exposure.
- Centers for Disease Control and Prevention. About Birth Defects.
- U.S. Drug Enforcement Administration. Facts about Fentanyl.
- Substance Abuse and Mental Health Services Administration. Buprenorphine.
- U.S. Food and Drug Administration. Pregnancy and Lactation Labeling Rule (PLLR) resources.
- Wadman E, et al. A novel syndrome associated with prenatal fentanyl exposure. Genetics in Medicine Open, 2023.
Patrick Bailey
I am a professional writer, mainly in the fields of mental health, addiction, and living in recovery. I attempt to stay on top of the latest news in the addiction and the mental health world and enjoy writing about these topics to break the stigma associated with them.
Patrick Bailey
I am a professional writer, mainly in the fields of mental health, addiction, and living in recovery. I attempt to stay on top of the latest news in the addiction and the mental health world and enjoy writing about these topics to break the stigma associated with them.